(8R,9S,10R,13S,14S)-17-(5-(difluoromethyl)pyridin-3-yl)-6,10,13-trimethyl-6,7, 8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-3(2H)-one

ID: ALA3973535

PubChem CID: 68087375

Max Phase: Preclinical

Molecular Formula: C26H31F2NO

Molecular Weight: 411.54

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1C[C@@H]2[C@H](CC[C@]3(C)C(c4cncc(C(F)F)c4)=CC[C@@H]23)[C@@]2(C)CCC(=O)C=C12

Standard InChI:  InChI=1S/C26H31F2NO/c1-15-10-19-21-5-4-20(16-11-17(24(27)28)14-29-13-16)25(21,2)9-7-22(19)26(3)8-6-18(30)12-23(15)26/h4,11-15,19,21-22,24H,5-10H2,1-3H3/t15?,19-,21-,22-,25+,26+/m0/s1

Standard InChI Key:  NHUAZHCIDQXGIK-DBUIOMFGSA-N

Molfile:  

     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   14.0622  -26.5577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8946  -25.7080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7632  -25.3261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3925  -25.5322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6834  -22.4486    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.9020  -26.5349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1891  -26.9520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0561  -25.7403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1676  -26.1203    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   16.8884  -24.8786    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   18.0725  -22.8078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6001  -24.4598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7781  -26.9661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3821  -24.1963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6300  -23.4094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4731  -25.7274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3166  -22.0220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8732  -24.8617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1669  -24.4715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1743  -25.2983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1257  -21.8396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8798  -24.0543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4805  -26.5474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5996  -26.1077    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   19.4356  -23.2347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6786  -23.6382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4541  -24.8928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6074  -25.2866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7569  -21.4160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9522  -21.5976    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   18.0020  -20.6281    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.1935  -27.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3503  -26.9747    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 12 26  1  1
 20  9  1  6
 23 16  1  0
  1 13  1  0
 16  3  1  0
  3  8  1  0
  4 18  1  0
  7  6  1  0
 22 19  1  0
 15 25  2  0
 28 12  1  0
 21 17  1  0
 20 16  1  0
  5 21  2  0
 23 13  2  0
 11 15  1  0
 18 14  2  0
  2 10  1  1
 28 24  1  6
 16 27  1  1
 14 12  1  0
 23  7  1  0
 25  5  1  0
  8  1  1  0
 14 15  1  0
 17 11  2  0
 19 20  1  0
  2 20  1  0
  2 28  1  0
 12 22  1  0
 28  4  1  0
  6  2  1  0
 17 29  1  0
 29 30  1  0
 29 31  1  0
  7 32  1  0
  1 33  2  0
M  END

Associated Targets(Human)

CYP17A1 Tclin Cytochrome P450 17A1 (3627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP21A2 Tchem Cytochrome P450 21 (835 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cyp11b2 Cytochrome P450 11B (409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 411.54Molecular Weight (Monoisotopic): 411.2374AlogP: 6.79#Rotatable Bonds: 2
Polar Surface Area: 29.96Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.10CX LogP: 5.21CX LogD: 5.21
Aromatic Rings: 1Heavy Atoms: 30QED Weighted: 0.54Np Likeness Score: 1.45

References

1.  (2013)  C-17-heteroaryl steroidal compounds as inhibitors of CYP11B, CYP17, and/or CYP21, 

Source